Paolo Carli appointed as the Head of MEA at Merck
Source: APO for Merck , Author: Posted by BI-ME staff
Posted: Sun October 1, 2017 2:36 pm

UAE. --APO-- Merck, one of the leading science and technology companies announced the appointment of Paolo Carli as Head of Middle East, Africa & Turkey (MEA) region for its healthcare business. In his new role, Paolo will be responsible for leading the commercial operations for Merck across MEA.

Commenting on his appointment Paolo Carli said “Merck prepares to celebrate its 350th year in the pharmaceutical business in 2018. Being a strategic region for Merck, we are committed to excel innovation and create value for patients across this region. I am delighted to lead the MEA team. Our innovative treatment options and sustainable commitment for patients will move us to the next level.”

Paolo Carli has decades of business and pharmaceutical experience demonstrating a proven track record of continuous success under his leadership. His expertise and industry knowledge will be critical in MEA as Merck builds on strategic innovation to elevate the healthcare standards, improve patient programs and prepares launches of new products.

Paolo Carli joined Merck in 2008, as the member of the Mergers & Acquisitions team in Darmstadt, Germany. In that role, he actively participated in the execution of key transactions for the Merck Group. He successfully led Middle East and Egypt in the last 5 years and now expands his responsibilities to Turkey and Africa.

Prior to joining Merck, Carli worked with Deutsche Bank, both in Italy and in Germany, where he successfully contributed to the regional expansion of the retail franchise in Europe and in several emerging markets such as India, China, Turkey, and Vietnam.

Paolo Carli holds a degree in Economics from the University of Turin and an Executive MBA from Ashridge Business School in the UK. Paolo is settled in Dubai, UAE with his wife and two children.

Distributed by APO on behalf of Merck.

Photo Captions:
1. (above)  Paolo Carli, Head of Middle East, Africa & Turkey (MEA) region
2. (inset)  For illustrative purposes (File photo)

About Merck:
Merck (www.MerckGroup.com) is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck generated sales of € 15.0 billion in 66 countries.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the “Merck” name and brand except in the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

 

MIDDLE EAST BUSINESS COMMENT & ANALYSIS

date:Posted: December 10, 2017
UAE. Declining reserves and revenues, along with rising domestic energy demand, require a shift to enable performance and sustainability.
date:Posted: December 9, 2017
UAE. Recent geopolitical developments on the regional front and new residential legislation in Dubai are both likely to impact the emirate's property market. 
date:Posted: December 9, 2017
INTERNATIONAL. Now's the time for a bold, forward-thinking company to stand up and challenge the new, established way of accepting everyone's ideas as equally valid.
dhgate